Abstract
Aim:
The enhancement of intracellular Ca2+ signaling in response to α1-adrenergic receptor (α1-AR) stimulation is an essential signal transduction event in the regulation of cardiac functions, such as cardiac growth, cardiac contraction, and cardiac adaptation to various situations. The present study was intended to determine the role(s) of the α1-AR subtype(s) in mediating this response.
Methods:
We evaluated the effects of subtype-specific agonists and antagonists of the α1-AR on the intracellular Ca2+ signaling of neonatal rat ventricular myocytes using a confocal microscope.
Results:
After being cultured for 48 h, the myocytes exhibited spontaneous local Ca2+ release, sparks, and global Ca2+ transients. The activation of the α1-AR with phenylephrine, a selective agonist of the α1-AR, dose-dependently increased the frequency of Ca2+ transients with an EC50 value of 2.3 μmol/L. Blocking the α1A-AR subtype with 5-methylurapidil (5-Mu) inhibited the stimulatory effect of phenylephrine with an IC50 value of 6.7 nmol/L. In contrast, blockade of the α1B-AR and α1D-AR subtypes with chlorethylclonidine and BMY 7378, respectively, did not affect the phenylephrine effect. Similarly, the local Ca2+ spark numbers were also increased by the activation of the α1-AR, and this effect could be abolished selectively by 5-Mu. More importantly, A61603, a novel selective α1A-AR agonist, mimicked the effect of phenylephrine, but with more potency (EC50 value=6.9 nmol/L) in the potentiation of Ca2+ transients, and blockade of the α1A-AR by 5-Mu caused abolishment of its effects.
Conclusion:
These results indicate that α1-adrenergic stimulation of intracellular Ca2+ activity is mediated selectively by the α1A-AR.
Similar content being viewed by others
Article PDF
References
Piascik MT, Perez DM . α1-Adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 2001; 298: 403–10.
Graham RM, Perez DM, Hwa J, Piascik MT . α1-Adrenergic receptor subtypes: molecular structure, function, and signaling. Circ Res 1996; 78: 737–49.
Lazou A, Fuller SJ, Bogoyevitch MA, Orfali KA, Sugden PH . Characterization of stimulation of phosphoinositide hydrolysis by α1-adrenergic agonists in adult rat hearts. Am J Physiol 1994; 267: H970–8.
Brodde OE, Michel MC . Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999; 51: 651–90.
Li K, He H, Li C, Sirois P, Rouleau JL . Myocardial alpha 1-adrenoceptor: inotropic effect and physiologic and pathologic implication. Life Sci 1997; 60: 1305–18.
O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson GL, et al. The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 2003; 111: 1783–91.
Harrison SN, Autelitano DJ, Wang BH, Milano C, Du XJ, Wood-cock EA . Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha 1B-adrenergic receptors. Circ Res 1998; 83: 1232–40.
Hunton DL, Lucchesi PA, Pang Y, Cheng X, Dell'Italia LJ, Marchase RB . Capacitative calcium entry contributes to nuclear factor of activated T cells nuclear translocation and hypertrophy in cardiomyocytes. J Biol Chem 2002; 277: 14266–73.
Tolg R, Kurz T, Ungerer M, Schreieck J, Gorge B, Richardt G . Influence of alpha- and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat hearts. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 62–8.
Mackenzie L, Bootman MD, Laine M, Berridge MJ, Thuring J, Holmes A, et al. The role of inositol 1,4,5-trisphosphate receptors in Ca2+ signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 2002; 541: 395–409.
Liu SJ, Kennedy RH . α1-Adrenergic activation of L-type calcium current in rat ventricular myocytes: perforated patch clamp recordings. Am J Physiol 1998; 274: H2203–7.
Sugden PH . Signaling in myocardial hypertrophy: life after calcineurin? Circ Res 1999; 84: 633–46.
Frey N, McKinsey TA, Olson EN . Decoding calcium signals involved in cardiac growth and function. Nat Med 2000; 6: 1221–7.
Luther HP, Podlowski S, Schulze W, Morwinski R, Buchwalow I, Baumann G, et al. Expression of alpha 1-adrenergic receptor subtypes in heart cell culture. Mol Cell Biochem 2001; 224: 69–79.
Stewart AF, Rokosh DG, Bailey BA, Karns LR, Chang KC, Long CS, et al. Cloning of the rat α1C-adrenergic receptor from cardiac myocytes: α1C, α1B, and α1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts. Circ Res 1994; 75: 796–802.
Lemire I, Ducharme A, Tardif JC, Poulin F, Jones LR, Allen BG, et al. Cardiac-directed overexpression of wild-type alpha 1B-adrenergic receptor induces dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2001; 281: H931–8.
Autelitano DJ, Woodcock EA . Selective activation of alpha 1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha 1-adrenergic receptor subtype mRNAs. J Mol Cell Cardiol 1998; 30: 1515–23.
Pönicke K, Schlüter KD, Heinroth-Hoffmann I, Seyfarth T, Goldberg M, Osten B, et al. Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: involvement of only α1-adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 2001; 364: 444–53.
Deng XF, Sculptoreanu A, Mulay S, Peri KG, Li JF, Zheng WH, et al. Crosstalk between alpha-1A and alpha-1B adrenoceptors in neonatal rat myocardium: implications in cardiac hypertrophy. J Pharmacol Exp Ther 1998; 286: 489–96.
Luo DL, Gao J, Lan XM, Wang G, Wei S, Xiao RP, et al. Role of inositol 1,4,5-trisphosphate receptors in α1-adrenergic receptor-induced cardiomyocyte hypertrophy. Acta Pharmacol Sin 2006; 27: 895–900.
Garcia KD, Shah T, Garcia J . Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice. Am J Physiol Cell Physiol 2004; 287: C1048–57.
Yokoyama H, Yasutake M, Avkiran M . α1-Adrenergic stimulation of sarcolemmal Na+-H+ exchanger activity in rat ventricular myocytes: evidence for selective mediation by the a1A-adrenoceptor subtype. Circ Res 1998; 82: 1078–85.
Li HT, Long CS, Gray MO, Rokosh DG, Honbo NY, Karliner JS . Cross talk between angiotensin AT 1 and alpha 1-adrenergic receptors: angiotensin II downregulates alpha 1a-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ Res 1997; 81: 396–403.
Laz TM, Forray C, Smith KE, Bard JA, Vaysse PJ, Branchek TA, et al. The rat homologue of the bovine α1C-adrenergic receptor shows the pharmacological properties of the classical α1A subtype. Mol Pharmacol 1994; 46: 414–22.
Perez DM, Piascik MT, Malik N, Gavin R, Graham RM . Cloning, expression, and tissue distribution of the rat homolog of the bovine α1C-adrenergic receptor provide evidence for its classification as the a1A subtype. Mol Pharmacol 1994; 46: 823–31.
Deng XF, Chemtob S, Varma DR . Characterization of α1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br J Pharmacol 1996; 119: 269–76.
Turnbull L, McCloskey DT, O'Connell TD, Simpson PC, Baker AJ . α1-Adrenergic receptor responses in α1AB-AR knockout mouse hearts suggest the presence of α1D-AR. Am J Physiol Heart Circ Physiol 2003; 284: H1104–H9.
Knepper SM, Buckner SA, Brune ME, DeBernardis JF, Meyer MD, Hancock AA . A-61603, a potent α1-adrenergic receptor agonist, selective for the α1A receptor subtype. J Pharmacol Exp Ther 1995; 274: 97–103.
Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H . Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc Res 2005; 67: 378–87.
Lanzafame AA, Turnbull L, Amiramahdi F, Arthur JF, Huynh H, Woodcock EA . Inositol phospholipids localized to caveolae in rat heart are regulated by alpha 1-adrenergic receptors and by ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006; 290: H2059–65.
Ravingerova T, Pancza D, Ziegelhoffer A, Styk J . Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K (ATP) channels. Physiol Res 2002; 51: 109–19.
Price DT, Lefkowitz RJ, Caron MG, Berkowitz D, Schwinn DA . Localization of mRNA for three distinct α1-adrenergic receptor subtypes in human tissues: implications for human α1-adrenergic physiology. Mol Pharmacol 1994; 45: 171–5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by grant from the National Natural Science Foundation (No 30470692).
Rights and permissions
About this article
Cite this article
Luo, Dl., Gao, J., Fan, Ll. et al. Receptor subtype involved in α1-adrenergic receptor-mediated Ca2+ signaling in cardiomyocytes. Acta Pharmacol Sin 28, 968–974 (2007). https://doi.org/10.1111/j.1745-7254.2007.00605.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00605.x
Keywords
This article is cited by
-
The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo
Metabolomics (2016)
-
Agonistic antibody to the α1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein
Molecular and Cellular Biochemistry (2010)
-
α1D-Adrenergic receptor insensitivity is associated with alterations in its expression and distribution in cultured vascular myocytes
Acta Pharmacologica Sinica (2009)